The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
Advaxis Inc. COM NEW 7624208 2,813 275,000 SH   SOLE   275,000 0 0
Advaxis Inc. W EXP 07/15/201 7624117 731 112,500 SH   SOLE   112,500 0 0
Alcobra Ltd SHS M2239P109 6,737 1,115,315 SH   SOLE   1,115,315 0 0
Aldeyra Therapeutics Inc COM 01438T106 792 135,800 SH   SOLE   135,800 0 0
Ampio Pharmaceuticals Inc. COM 03209T109 9,792 3,388,322 SH   SOLE   3,388,322 0 0
Aptose Biosciences Inc COM NEW 03835T200 51 11,933 SH   SOLE   11,933 0 0
Bio Blast Pharma Ltd SHS M20156101 1,721 338,110 SH   SOLE   338,110 0 0
Caladrius Biosciences Inc COM 128058104 1,490 1,000,000 SH   SOLE   1,000,000 0 0
Corbus Pharmaceuticals HLDGS COM 21833P103 4,325 2,750,000 SH   SOLE   2,750,000 0 0
Evoke Pharma Inc COM 30049G104 162 55,660 SH   SOLE   55,660 0 0
Galmed Pharmaceuticals Ltd SHS M47238106 483 65,000 SH   SOLE   65,000 0 0
Keryx Biopharmaceuticals Inc. COM 492515101 704 200,000 SH   SOLE   200,000 0 0
Lion Biotechnologies Inc COM 53619R102 559 97,100 SH   SOLE   97,100 0 0
Medivation, Inc. COM 58501N101 186,908 4,397,838 SH   SOLE   4,397,838 0 0
Newlink Genetics Corp COM 651511107 3,671 102,437 SH   SOLE   102,437 0 0
OHR Pharmaceutical Inc COM NEW 67778H200 566 205,000 SH   SOLE   205,000 0 0
Abeona Therapeutics Inc COM 00289Y107 5,507 1,359,767 SH   SOLE   1,359,767 0 0
Synthetic Biologics Inc. COM 87164U102 8,477 3,734,149 SH   SOLE   3,734,149 0 0
Zosano Pharma Corp COM 98979H103 74 18,600 SH   SOLE   18,600 0 0